While our study focused on the Aβ-driven NLRP3 activation via the COX-1–PGE2–EP2 axis, it is important to note that multiple pathways contribute to NLRP3 inflammasome priming in AD. The gene discussed is NLRP3; the disease is Alzheimer disease.